NHC vs. VRTX
NHC (National HealthCare Corporation) and VRTX (Vertex Pharmaceuticals Incorporated) are both stocks. Both are in the Healthcare sector — NHC in Medical Care Facilities, VRTX in Biotechnology. Over the past 10 years, NHC returned 16.41%/yr vs 16.48%/yr for VRTX. Their 0.16 correlation means their historical movements had little consistent relationship.
Performance
NHC vs. VRTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NHC achieves a 63.67% return, which is significantly higher than VRTX's 3.83% return. Both investments have delivered pretty close results over the past 10 years, with NHC having a 16.41% annualized return and VRTX not far ahead at 16.48%.
NHC
- 1D
- -1.45%
- 1M
- 1.98%
- 6M
- 50.29%
- YTD
- 63.67%
- 1Y
- 139.61%
- 3Y*
- 55.68%
- 5Y*
- 27.29%
- 10Y*
- 16.41%
- ALL TIME*
- 10.42%
VRTX
- 1D
- -1.34%
- 1M
- -10.86%
- 6M
- -0.27%
- YTD
- 3.83%
- 1Y
- 1.86%
- 3Y*
- 11.40%
- 5Y*
- 18.72%
- 10Y*
- 16.48%
- ALL TIME*
- 14.15%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $22.22M | $23.57M | $26.02M | |
| $643.91M | $710.52M | $724.94M |
NHC vs. VRTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NHC National HealthCare Corporation | 63.67% | 30.34% | 19.05% | 60.84% | -9.42% | 5.39% | -20.66% | 13.02% | 32.43% | -17.26% |
VRTX Vertex Pharmaceuticals Incorporated | 3.83% | 12.58% | -1.03% | 40.90% | 31.50% | -7.08% | 7.94% | 32.13% | 10.58% | 103.42% |
Correlation
The correlation between NHC and VRTX is 0.17, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.17 |
Correlation (3Y) Balances recent behavior with more history. | 0.14 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.17 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.16 |
Correlation (All Time) Calculated using the full available price history since Jul 24, 1991 | 0.16 |
Fundamentals
NHC:
$3.48B
VRTX:
$119.47B
NHC:
$7.88
VRTX:
$17.18
NHC:
28.27
VRTX:
27.40
NHC:
0.62
VRTX:
2.28
NHC:
2.31
VRTX:
9.56
NHC:
3.22
VRTX:
4.39
NHC:
$1.51B
VRTX:
$12.62B
NHC:
$558.31M
VRTX:
$10.86B
NHC:
$204.52M
VRTX:
$5.39B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NHC vs. VRTX — Risk / Return Rank
NHC
VRTX
NHC vs. VRTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for National HealthCare Corporation (NHC) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NHC | VRTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.27 | ||
| Sortino ratioReturn per unit of downside risk | +4.75 | ||
| Omega ratioGain probability vs. loss probability | 1.62 | 1.05 | +0.57 |
| Calmar ratioReturn relative to maximum drawdown | 13.93 | 0.08 | +13.85 |
| Martin ratioReturn relative to average drawdown | 36.69 | 0.17 | +36.52 |
Loading charts...
Drawdowns
NHC vs. VRTX - Drawdown Comparison
The maximum NHC drawdown since its inception was -96.33%, roughly equal to the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for NHC and VRTX.
Loading charts...
Drawdown Indicators
| NHC | VRTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.33% | -91.77% | -4.56% |
Max Drawdown (1Y)Largest decline over 1 year | -10.08% | -22.39% | +12.31% |
Max Drawdown (3Y)Largest decline over 3 years | -33.40% | -29.07% | -4.33% |
Max Drawdown (5Y)Largest decline over 5 years | -33.40% | -29.07% | -4.33% |
Max Drawdown (10Y)Largest decline over 10 years | -35.27% | -41.60% | +6.33% |
Current DrawdownCurrent decline from peak | -3.57% | -11.12% | +7.55% |
Average DrawdownAverage peak-to-trough decline | -26.33% | -37.62% | +11.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.82% | 10.99% | -7.17% |
Volatility
NHC vs. VRTX - Volatility Comparison
National HealthCare Corporation (NHC) has a higher volatility of 8.35% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 6.85%. This indicates that NHC's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NHC | VRTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.35% | 6.85% | +1.50% |
Volatility (6M)Calculated over the trailing 6-month period | 25.57% | 21.35% | +4.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.53% | 34.88% | -2.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.91% | 28.77% | -0.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.39% | 32.73% | -4.34% |
Dividends
NHC vs. VRTX - Dividend Comparison
NHC's dividend yield for the trailing twelve months is around 1.16%, while VRTX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NHC National HealthCare Corporation | 1.16% | 1.85% | 2.25% | 2.53% | 3.80% | 3.11% | 3.13% | 2.38% | 2.52% | 3.10% | 2.31% | 3.14% |
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NHC vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between National HealthCare Corporation and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NHC vs. VRTX - Profitability Comparison
NHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, National HealthCare Corporation reported a gross profit of 0.00 and revenue of 369.81M. Therefore, the gross margin over that period was 0.0%.
VRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.84B and revenue of 3.33B. Therefore, the gross margin over that period was 85.3%.
NHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, National HealthCare Corporation reported an operating income of 32.25M and revenue of 369.81M, resulting in an operating margin of 8.7%.
VRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Vertex Pharmaceuticals Incorporated reported an operating income of 1.25B and revenue of 3.33B, resulting in an operating margin of 37.4%.
NHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, National HealthCare Corporation reported a net income of 35.86M and revenue of 369.81M, resulting in a net margin of 9.7%.
VRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Vertex Pharmaceuticals Incorporated reported a net income of 1.10B and revenue of 3.33B, resulting in a net margin of 33.0%.
Frequently Asked Questions
NHC and VRTX have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NHC has higher volatility (8.35%) compared to VRTX (6.85%). In terms of maximum drawdown, NHC dropped -96.33% vs VRTX's -91.77%.
NHC currently has the higher Sharpe Ratio (4.33 vs 0.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NHC and VRTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer